Mahesh S. Mulumudi

Mahesh Mulumudi practices at Providence Regional Medical Center - Everett in Everett, Washington.

Mahesh Mulumudi's NPI, 1013972488, was assigned on April 19, 2006. Mahesh Mulumudi holds Washington license MD00045084.

Mahesh Mulumudi's primary practice is Providence Regional Medical Center - Everett, at 1700 13th St, Everett, WA 98201 in Snohomish County. The practice phone is (425) 261-2000.

Mahesh Mulumudi's primary practice is Providence Regional Medical Center - Everett in Everett, Washington. Mahesh Mulumudi is also affiliated with Providence Regional Medical Center Everett. The medical group on file is The Everett Clinic. Dmand AI also links Mahesh Mulumudi to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mahesh Mulumudi practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Mahesh Mulumudi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Mahesh Mulumudi is licensed in Washington.

CMS data shows 944 Medicare services from Mahesh Mulumudi across 21 procedure codes in 2024, for 503 Medicare patients. Medicare paid $133,410 for them.

CMS counts 503 Medicare patients who saw Mahesh Mulumudi in 2024. The largest group is 75 to 84, with 233 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mahesh Mulumudi's median patient age at 76, with 44% women.

In 2024, Mahesh Mulumudi wrote 815 Medicare Part D claims for 228 patients. 82% of them were for generic drugs. CMS names the drug for 682 of them, across 18 drugs with 11 or more claims each, at $119,624 in total drug cost. In 2023, CMS named 781 claims across 20 drugs.

Mahesh Mulumudi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mahesh Mulumudi as offering telehealth. CMS counts 17 procedures of coronary angioplasty and stenting by Mahesh Mulumudi, more than 44% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Mahesh Mulumudi to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Coronary Restenosis, Stroke and Cerebrovascular Disorders.

CMS Open Payments shows 212 general payments to Mahesh Mulumudi from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 41% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $9,940.